FEATURE ARTICLES
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.
- 4 Ways To Building A Better CMC Tech Transfer
- The Reliance Trap: When Regulatory Strategy Becomes A Clinical Supply Problem
- What FDA Inspectors Want From Your OOS File
- AI Fills The Decision-Making Gaps In Process Analytical Technology
- You Can't CAPA What You Can't Classify
- Why Supplier Diversification Doesn't Ensure Supply Safety
- Oral Combination Therapies: Navigating Development Complexities
PHARMA ONLINE WHITE PAPERS
-
Single-Use Technology And Environmental Responsibility In Biopharmaceuticals
Learn about strategies such as regional manufacturing and advanced single-use systems and their potential to minimize carbon footprint and enhance sustainable biomanufacturing.
-
Late‑Stage Progress In Excipients For Precision Nanomedicine5/6/2026
View late‑stage development and GMP manufacturing of novel excipients for nanomedicines, emphasizing regulatory rigor, process optimization, analytics, and scale‑up for lipid‑based delivery systems.
-
The Open Standard For Plug-And-Produce4/14/2026
Take a look at how standardized, modular production simplifies line integration, reduces engineering effort, and enables faster changeovers. Ideal for teams seeking flexible manufacturing models.
-
The Evolution Of EAM/CMMS In Pharma Manufacturing8/8/2025
Explore pharma’s shift from paper-based maintenance to modern EAM/CMMS that shows how digital tools boost compliance, reduce downtime, and improve data accuracy and productivity.
-
The Connectivity Crisis Blocking AI Deployment6/30/2026
Disconnected systems and siloed data block analytics in life sciences manufacturing. Learn to bridge the infrastructure gap and build a connected foundation for scalable intelligence.
-
A Shift Towards Biofluorescent Particle Counters In Manufacturing5/12/2025
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Biopharma Production And Quality Control With Electrophoresis
- Asset Reinduction To Maximo EAM, Enabled By Reality Capture
- Environmental Monitoring In Advanced Therapeutic Medicinal Products Facilities
- Enhanced mAb Production With High-Intensity Perfusion CHO Medium
- How Sharp Packaging's Clinical Packaging Process Is 30% Faster
NEWSLETTER ARCHIVE
- 09.28.26 -- The Integrated Path To Injectable Success
- 09.25.26 -- What FDA Inspectors Want From Your OOS File
- 09.24.26 -- How Top CDMOs Are Accelerating Speed To IND
- 09.24.26 -- Why Supplier Diversification Doesn't Ensure Supply Safety
- 09.24.26 -- How Emerging Technology Will Reshape Pharma Operations
INDUSTRY NEWS
-
Let Your Voice Help Shape Pharma Manufacturing
Pharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
ISPE Announces 2026 FOYA Winners
These awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
Høeg In, Pazdur Out At The FDA
What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
9 Drugs Granted Fast Track By FDA's Voucher Program
With targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
Leaders In The Excipient Market: Region And Type
Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Rottendorf Pharma Is CDMO Leadership Award Winner 20259/28/2026
Thanks to overwhelmingly positive customer feedback, Rottendorf Pharma has been awarded the CDMO Leadership Award 2025 in the category of "Small Molecule Dosage Form - International."
-
Top Employer 2025: Rottendorf Pharma Receives International Award9/28/2026
Rottendorf Pharma has been recognized as a Top Employer 2025 in Germany. The Top Employer Institute, headquartered in Amsterdam, has assessed and certified more than 2,400 companies in 125 countries.
-
New Gerteis Roller Compactors: Rottendorf Pharma Invests Millions In State-Of-The-Art Technology9/28/2026
Rottendorf Pharma has commissioned a new dry granulation system from Swiss manufacturer Gerteis Maschinen + Processengineering AG at its Ennigerloh site.
-
Rottendorf Pharma To Double Long-Term Manufacturing Capacity With New Campus9/28/2026
Rottendorf Pharma has officially begun construction of the Rottendorf Campus in Oelde, Germany, a major investment aimed at expanding manufacturing capacity for the global pharmaceutical industry.